Brief: NanoVibronix Reports First Quarter 2022 Financial Results

ENvue Medical

17/05/2022 13:48

May 17 (Reuters) - Nanovibronix Inc  NAOV.O :
    * NANOVIBRONIX REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
    * NANOVIBRONIX INC - QTRLY NET LOSS AVAILABLE FOR HOLDERS OF
COMMON STOCK, SERIES C PREFERRED STOCK AND SERIES D PREFERRED
STOCK $0.04

Source text for Eikon:  ID:nBw4ybDJba 
Further company coverage:  NAOV.O 

 ((Reuters.Briefs@thomsonreuters.com;))